Ypsomed Holding AG (SWX:YPSN)

Market Cap	4.71B
Revenue (ttm)	787.55M
Net Income (ttm)	194.00M
Shares Out	13.65M
EPS (ttm)	14.21
PE Ratio	24.31
Forward PE	25.64
Dividend	2.20 (0.64%)
Ex-Dividend Date	Jul 4, 2025

Volume	12,530
Average Volume	14,138
Open	345.00
Previous Close	343.50
Day's Range	343.50 - 348.00
52-Week Range	291.50 - 441.50
Beta	0.99
RSI	73.80
Earnings Date	Feb 11, 2026

About Ypsomed Holding AG

Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for safe and simple self-medication companies. The company operates through three segments: Ypsomed Delivery Systems, Ypsomed Diabetes Care, and Others. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto-injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insu...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1984
• Employees: 2,644
• Stock Exchange: SIX Swiss Exchange
• Ticker Symbol: YPSN

Financial Performance

In 2024, Ypsomed Holding AG's revenue was 748.87 million, an increase of 36.54% compared to the previous year's 548.46 million. Earnings were 87.50 million, an increase of 11.66%.